Potentiating effect of endothelial cells on astrocytic plasminogen activator inhibitor type-1 gene expression in an in vitro model of the blood-brain barrier

Neuroscience

Volumn 166, Issue 2, 2010, Pages 408-415

  Hultman, K ^a,b   Bjorklund U ^a   Hansson, E ^a   Jern, C ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelial astrocyte cocultures; Plasminogen activator inhibitor type 1; Protease nexin 1; Tissue type plasminogen activator

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE NEXIN I; TISSUE PLASMINOGEN ACTIVATOR; SERINE PROTEINASE INHIBITOR; SERPINE2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL CULTURE; CELL JUNCTION; COCULTURE; CONTROLLED STUDY; DEVELOPMENTAL GENE; ENDOTHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; NEWBORN; NONHUMAN; PAI 1 GENE; PN 1 GENE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; T PA GENE; ANIMAL; BRAIN; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77951904498     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.01.002     Document Type: Article

References (34)

1. Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53.
2. Abbott NJ, Hughes CC, Revest PA, Greenwood J (1992) Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci 103:23-37.
3. Bauer HC, Bauer H (2000) Neural induction of the blood-brain barrier: still an enigma. Cell Mol Neurobiol 20:13-28.
4. Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, Gulino A (2000) Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12:1002-1012.
5. Choi BH, Suzuki M, Kim T, Wagner SL, Cunningham DD (1990) Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am J Pathol 137:741-747.
6. De Stefano ME, Leone L, Moriconi C, Del Signore A, Petrucci TC, Paggi P (2007) Involvement of the plasminogen enzymatic cascade in the reaction to axotomy of rat sympathetic neurons. Mol Cell Neurosci 36:174-184.
7. Delbro D, Westerlund A, Björklund U, Hansson E (2009) In inflammatory reactive astrocytes co-cultured with brain endothelial cells nicotine-evoked Ca(2+) transients are attenuated due to interleukin-1beta release and rearrangement of actin filaments. Neuroscience 159:770-779.
8. Descamps L, Coisne C, Dehouck B, Cecchelli R, Torpier G (2003) Protective effect of glial cells against lipopolysaccharide-mediated blood-brain barrier injury. Glia 42:46-58.
9. Emeis JJ (1992) Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N Y Acad Sci 667:249-258.
10. Emeis JJ, Kooistra T (1986) Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 163:1260-1266.
11. Emsley HC, Smith CJ, Tyrrell PJ, Hopkins SJ (2008) Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit Care 9:125-138.
12. Estrada C, Bready JV, Berliner JA, Pardridge WM, Cancilla PA (1990) Astrocyte growth stimulation by a soluble factor produced by cerebral endothelial cells in vitro. J Neuropathol Exp Neurol 49: 539-549.
13. Faber-Elman A, Miskin R, Schwartz M (1995) Components of the plasminogen activator system in astrocytes are modulated by tumor necrosis factor-alpha and interleukin-1beta through similar signal transduction pathways. J Neurochem 65:1524-1535.
14. Gravanis I, Tsirka SE (2005) Tissue plasminogen activator and glial function. Glia 49:177-183.
15. Hansson E, Rönnback L, Persson LI, Lowenthal A, Noppe M, Alling C, Karlsson B (1984) Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum. Brain Res 300:9-18.
16. Hansson E, Westerlund A, Björklund U, Olsson T (2008) mu-Opioid agonists inhibit the enhanced intracellular Ca(2+) responses in inflammatory activated astrocytes co-cultured with brain endothelial cells. Neuroscience 155:1237-1249.
17. Haseloff RF, Blasig IE, Bauer HC, Bauer H (2005) In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol 25:25-39.
18. Kielian T (2006) Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83:711-730.
19. Kim JA, Tran ND, Li Z, Yang F, Zhou W, Fisher MJ (2006) Brain endothelial hemostasis regulation by pericytes. J Cereb Blood Flow Metab 26:209-217.
20. Kim JA, Tran ND, Wang SJ, Fisher MJ (2003) Astrocyte regulation of human brain capillary endothelial fibrinolysis. Thromb Res 112: 159-165.
21. Kondo T, Kinouchi H, Kawase M, Yoshimoto T (1996) Astroglial cells inhibit the increasing permeability of brain endothelial cell monolayer following hypoxia/reoxygenation. Neurosci Lett 208:101-104.
22. Lee SY, Kim HJ, Lee WJ, Joo SH, Jeon SJ, Kim JW, Kim HS, Han SH, Lee J, Park SH, Cheong JH, Kim WK, Ko KH, Shin CY (2008) Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharide-stimulated rat primary astrocytes. Neurochem Res 33:2324-2334.
23. Morganti-Kosmann MC, Kossmann T, Brandes ME, Mergenhagen SE, Wahl SM (1992) Autocrine and paracrine regulation of astrocyte function by transforming growth factor-beta. J Neuroimmunol 39: 163-173.
24. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006) Bloodbrain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1:223-236.
25. Schroeter ML, Mertsch K, Giese H, Muller S, Sporbert A, Hickel B, Blasig IE (1999) Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier. FEBS Lett 449:241-244.
26. Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731-737.
27. Tontsch U, Bauer HC (1991) Glial cells and neurons induce bloodbrain barrier related enzymes in cultured cerebral endothelial cells. Brain Res 539:247-253.
28. Tran ND, Schreiber SS, Fisher M (1998) Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model. J Cereb Blood Flow Metab 18:1316-1324.
29. Treichel JA, Reddington M, Kreutzberg GW (1998) Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-beta1 in cultured rat astrocytes. J Neurochem 71:1944-1952.
30. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543-552.
31. Wang X, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, Lo EH (2003) Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 9:1313-1317.
32. Weiss N, Miller F, Cazaubon S, Couraud PO (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788:842-857.
33. Wolf AT, Medcalf RL, Jern C (2005) The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid. Blood 105:1060- 1067.
34. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112:1533-1540.